These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36901465)

  • 1. A National Portrait of Public Attitudes toward Opioid Use in the US: A Latent Class Analysis.
    Walters SM; Liu W; Lamuda P; Huh J; Brewer R; Johnson O; Bluthenthal RN; Taylor B; Schneider JA
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social Stigma Toward Persons With Prescription Opioid Use Disorder: Associations With Public Support for Punitive and Public Health-Oriented Policies.
    Kennedy-Hendricks A; Barry CL; Gollust SE; Ensminger ME; Chisolm MS; McGinty EE
    Psychiatr Serv; 2017 May; 68(5):462-469. PubMed ID: 28045350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Support for evidence-informed opioid policies and interventions: The role of racial attitudes, political affiliation, and opioid stigma.
    Pyra M; Taylor B; Flanagan E; Hotton A; Johnson O; Lamuda P; Schneider J; Pollack HA
    Prev Med; 2022 May; 158():107034. PubMed ID: 35339585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults.
    Adams ZW; Taylor BG; Flanagan E; Kwon E; Johnson-Kwochka AV; Elkington KS; Becan JE; Aalsma MC
    J Adolesc Health; 2021 Aug; 69(2):321-328. PubMed ID: 33579622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social Stigma toward Persons with Opioid Use Disorder: Results from a Nationally Representative Survey of U.S. Adults.
    Taylor BG; Lamuda PA; Flanagan E; Watts E; Pollack H; Schneider J
    Subst Use Misuse; 2021; 56(12):1752-1764. PubMed ID: 34315335
    [No Abstract]   [Full Text] [Related]  

  • 6. The unique nature of public stigma toward non-medical prescription opioid use and dependence: a national study.
    Perry BL; Pescosolido BA; Krendl AC
    Addiction; 2020 Dec; 115(12):2317-2326. PubMed ID: 32219910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Use Disorder Stigma and Support for Harm Reduction in Rural Counties.
    Whipple CR; Kaynak Ö; Kruis NE; Saylor E; Bonnevie E; Kensinger WS
    Subst Use Misuse; 2023; 58(14):1818-1828. PubMed ID: 37622487
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment.
    Pytell JD; Chander G; Thakrar AP; Ogunwole SM; McGinty EE
    J Gen Intern Med; 2023 May; 38(7):1638-1646. PubMed ID: 36394698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responding to the US opioid crisis: leveraging analytics to support decision making.
    Brandeau ML
    Health Care Manag Sci; 2023 Dec; 26(4):599-603. PubMed ID: 37804456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community.
    Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process.
    Grant S; Smart R; Gordon AJ; Pacula RL; Stein BD
    J Addict Med; 2024 Mar-Apr 01; 18(2):129-137. PubMed ID: 38039084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Competing Narratives on Public Perceptions of Opioid Pain Reliever Addiction during Pregnancy.
    Kennedy-Hendricks A; McGinty EE; Barry CL
    J Health Polit Policy Law; 2016 Oct; 41(5):873-916. PubMed ID: 27256811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
    Adeosun SO
    J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between partisan media consumption, opioid use disorder stigma, and opioid policy support: An exploration of the media's role in the ongoing opioid epidemic.
    Kresovich A; Emery SL; Borowiecki M; McQueen C; Ngobo-Ekamby M; Lamuda PA; Taylor BG; Pollack HA; Schneider JA
    Prev Med Rep; 2023 Dec; 36():102430. PubMed ID: 37840592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study.
    Davis A; Stringer KL; Drainoni ML; Oser CB; Knudsen HK; Aldrich A; Surratt HL; Walker DM; Gilbert L; Downey DL; Gardner SD; Tan S; Lines LM; Vandergrift N; Mack N; Holloway J; Lunze K; McAlearney AS; Huerta TR; Goddard-Eckrich DA; El-Bassel N
    Int J Drug Policy; 2023 Dec; 122():104241. PubMed ID: 37890391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population.
    Bascou NA; Haslund-Gourley B; Amber-Monta K; Samson K; Goss N; Meredith D; Friedman A; Needleman A; Kumar VK; Fischer BD
    Harm Reduct J; 2022 Jan; 19(1):5. PubMed ID: 35034649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of stigma in U.S. primary care physicians' treatment of opioid use disorder.
    Stone EM; Kennedy-Hendricks A; Barry CL; Bachhuber MA; McGinty EE
    Drug Alcohol Depend; 2021 Apr; 221():108627. PubMed ID: 33621805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of stigmatizing language describing opioid-exposed mother infant dyads: A randomized case vignette study.
    Schiff DM; Halvorson AE; Dupont W; Davis MM; Patrick SW
    Subst Abus; 2022; 43(1):551-555. PubMed ID: 34586979
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.
    Tabatabaeepour N; Morgan JR; Jalali A; Kapadia SN; Meinhofer A
    J Subst Abuse Treat; 2022 Sep; 140():108800. PubMed ID: 35577664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.